Jim is an established lead trial counsel with numerous recent jury and bench trial victories in bet-the-company cases in courtrooms across the country. His litigation successes for client Nova Biomedical, which faced formidable opposition from three leading life sciences companies, are highlighted in a recent Forbes magazine article. Jim recently has been featured as American Lawyer's “Litigator of the Week” for his successes in the landmark Therasense inequitable conduct case. Further on the basis of his work on this case, Jim and his team were recently ranked number 1 in the nation “lawyers to the innovators” by the Financial Times in its Innovative Lawyers Report “FT Law 25.”

Jim’s patent trial and litigation practice includes all technologies, but is focused primarily in the medical device, biotechnology and pharmaceutical industries, including litigation under the Hatch–Waxman Act. Jim is a pioneer in medical device patent litigation, having continuously litigated cases involving medical device patents for more than 25 years. His cases have involved a wide range of medical device technology, including blood glucose devices, surgical staplers, laparoscopic instruments and coronary stents. His cases in the pharmaceutical industry have included a number of life-saving drugs such as recombinant Factor VIII used in the treatment of hemophilia. Based on his extensive experience in life sciences cases, Jim has been featured as a “Life Sciences Star” in Euromoney’s LMG Life Sciences 2012 and 2013.

In addition to his trial work, Jim appears regularly before the Court of Appeals for the Federal Circuit, having argued six cases before the Court in the past two years, including one (Therasense) in which the Court sat en banc. Benchmark Appellate has named Jim as a Court of Appeals for the Federal Circuit “Star,” one of less than fifty lawyers in the country to achieve this distinction.
- See more at: http://www.fishneave.com/ko-KR/biographies/b/bradford-j-badke.aspx#sthash.JasHjdnm.dpuf